Seqens Seqens

X

Digital content for Ascend Labs

  • Webinars & Exhibitions

PharmaCompass
Send me more info on How To Grow My Bussiness Digitally?
Ascend Labs
United_States_of_America Flag
Country
Country
U.S.A
Address
Address
339 Jefferson Road Suite 101 Parsippany, NJ 07054
Telephone
Telephone
(201)476-1977
Linkedin
Linkedin
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-february-28-2024-59068.pdf

FDA
28 Feb 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-24-2024-24602.pdf

FDA
24 Jan 2024

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-september-13-2023-60327.pdf

FDA
13 Sep 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-july-26-2023-55742.pdf

FDA
26 Jul 2023

https://endpts.com/ascend-launches-with-130m-as-it-looks-to-build-in-the-aav-space/

Tyler Patchen ENDPTS
09 May 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-26-2023-60580.pdf

FDA
26 Apr 2023

https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-april-5-2023-55870.pdf

FDA
05 Apr 2023

https://www.fiercepharma.com/manufacturing/ascend-recalls-10-lots-anticoagulant-pills-due-carcinogens

Joseph Keenan FIERCE PHARMA
23 Mar 2023

https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/ascend-laboratories-llc-issues-voluntary-nationwide-recall-dabigatran-etexilate-capsules-usp-75-mg

FDA
22 Mar 2023

https://www.accessdata.fda.gov/scripts/ires/index.cfm?action=print.getPrintData&ts=11202310416

FDA
01 Feb 2023
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY